87.49
[1]. Heyes MP, et al. Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease. Brain. 199 Oct;115 ( Pt 5):149-7.
[]. Jang S, et al. Neuroprotective effects of (-)-epigallocatechin--gallate against quinolinic acid-induced excitotoxicity via PIK pathway and NO inhibition. Brain Res. 010 Feb 8;11:5-.
[]. Arun Sreekumar, et al. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature. 009 Feb 1;457(71):910-4.
[4]. C Blázquez, et al. The CB? cannabinoid receptor signals striatal neuroprotection via a PIK/Akt/mTORC1/BDNF pathway. Cell Death Differ. 015 Oct;(10):1618-9.
[5]. Edwin B Yan, et al. Activation of the kynurenine pathway and increased production of the excitotoxin quinolinic acid following traumatic brain injury in humans. J Neuroinflammation. 015 May 0:1:110.
H19-H5
P61-P64-P71-P80-P04+P40-P405-P501